Skip to main content

Table 4 Adjusted effect estimates (aOR CI 95%) for associations with RC, allergic RC and non-allergic RC at 14 years of age

From: Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study

 

RC

RC inc. s-IgE ≥ 4.00 SU/ml

Allergic RC

Allergic RC inc s-IgE ≥ 4.00 SU/ml

Non-allergic RC

aOR (CI 95%)

aOR (CI 95%)

aOR (CI 95%)

aOR (CI 95%)

aOR (CI 95%)

Gender

1.26 (0.78–2.04)

1.30 (0.80–2.12)

1.90 (1.06–3.41)*

2.08 (1.14–3.81)*

0.64 (0.31–1.32)

FH

2.01 (1.25–3.23)*

2.01 (1.24–3.26)*

2.25 (1.27–3.99)*

2.32 (1.28–4.18)*

1.45 (0.72–2.92)

Early sensitization to inhalant allergens

1.31 (0.78–2.20)

 

1.65 (0.91–3.02)

 

NI

Early sensitization to foods

1.62 (0.99–2.67)*

 

1.57 (0.86–2.87)

 

NI

s-IgE ≥ 4.00 SU/ml to inhalant allergens

 

2.03 (1.06–3.90)*

 

2.92 (1.43–5.96)*

NI

s-IgE ≥ 4.00 SU/ml to food allergens

 

2.38 (1.15–4.93)*

 

3.13 (1.41–6.95)*

NI

FA

3.49 (1.00–12.16)

2.36 (0.62–8.92)

3.89 (1.08–14.08)*

2.08 (0.52–8.31)

NI

AD

2.44 (1.37–4.33)*

2.11 (1.17–3.81)*

3.24 (1.72–6.12)*

2.68 (1.38–5.19)*

NI

ETS

0.42 (0.26–0.69)*

0.42 (0.26–0.69)*

0.47 (0.26–0.83)*

0.48 (0.27–0.87)*

0.43 (0.20–0.92)*

Maternal tobacco smoking in pregnancy

NI

NI

NI

NI

0.56 (0.21–1.46)

Older siblings

0.64 (0.40–1.03)

0.66 (0.41–1.07)

0.53 (0.30–0.94)*

0.55 (0.31–1.00)

 
  1. NI not included due to univariate logistic regression analysis
  2. P ≤ 0.05